High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients

计划入组 520 人 · 首次发布于 2008 年 11 月 4 日

Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

计划入组 1,200 人 · 首次发布于 2009 年 1 月 6 日

Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma

计划入组 12 人 · 首次发布于 2014 年 10 月 27 日

AbyD-3263

ABOD-2011

BVD-TEM8

SARA HASSAN ABD ELFATTAH MOHAMED HASSAN AND PARTNER

Egypt

Long-Term Study Shows PET-Guided Treatment Success in Early-Stage Hodgkin Lymphoma

Nivolumab Plus Chemotherapy Improves PFS in Advanced Hodgkin Lymphoma

Lenalidomide Plus PD-1 Inhibitor Achieves Sustained Remission in Relapsed Hodgkin Lymphoma Case